PDCD1 and neoplasm: Seven immune escape mechanisms for ineffective immune mediated anti-tumor response to anti-PD-1/PD-L1 therapy have been previously described (94, 95), and can be broadly summarized into three categories, namely 1) T-cell priming and activation, 2) T-cell trafficking and infiltration, and 3) tumor cell recognition and killing.